Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Income from Continuing Operations (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Income from Continuing Operations for 16 consecutive years, with 3371000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 1127.74% to 3371000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 57229000.0 through Dec 2025, down 375.84% year-over-year, with the annual reading at 57253000.0 for FY2025, 373.36% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 3371000.0 at Harvard Bioscience, down from 1234000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 2435000.0 in Q2 2022, with the low at 50340000.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 4133700.0, with a median of 1414500.0 recorded in 2023.
  • Peak annual rise in Income from Continuing Operations hit 693.9% in 2022, while the deepest fall reached 1902.94% in 2022.
  • Over 5 years, Income from Continuing Operations stood at 590000.0 in 2021, then tumbled by 382.37% to 1666000.0 in 2022, then grew by 4.56% to 1590000.0 in 2023, then surged by 120.63% to 328000.0 in 2024, then crashed by 1127.74% to 3371000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 3371000.0, 1234000.0, and 2284000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.